Depression is higher in pain patients receiving opioids compared to those receiving cannabis

Depression is higher in pain patients receiving opioids compared to those receiving cannabis

Di: IACM Terapeutico

In a study with 880 chronic pain patients treated at several centres in Israel those, who received prescription opioids had higher rates of depression and anxiety than those treated with cannabis. Of all participants 474 received opioids, 329 cannabis and 77 both opioids and cannabis. Depression and anxiety were assessed using the depression module of the Patient Health Questionnaire and the Generalized Anxiety Disorder scale.

Prevalence of depression among patients in the opioid group was 57.1%, in the cannabis group 22.3% and in those receiving both medications 51.4%. Rates of anxiety were 48.4%, 21.5% and 38.7%, respectively. Authors concluded: “levels of depression and anxiety are higher among chronic pain patients receiving prescription opioids compared to those receiving MM [medical marijuana]. Findings should be taken into consideration when deciding on the most appropriate treatment modality for chronic pain, particularly among those at risk for depression and anxiety.”

Source: IACM Bulletin

Kannabia seed Company vende ai suoi clienti un prodotto da collezione, un souvenir. Non possiamo e non dobbiamo dare consigli sulla coltivazione perché il nostro prodotto non è destinato a tale scopo.

Non siamo responsabili dell’uso illecito che potrebbe essere fatto da parte di terzi delle informazioni qui pubblicate. La coltivazione della cannabis per autoconsumo è un’attività soggetta a determinate restrizioni legali che variano da stato a stato. Si consiglia di rivedere la normativa vigente nel Paese di residenza per evitare di incorrere nello svolgimento di un’attività illecita.

Condividere: